KE
ETF Provider
KellyETFs
Total ETFs
4
All Products
4 ETFsName | Asset class | AUM | Durch. Volume | Provider | Expense Ratio | Investment Segment | Index | Launch date | NAV (Net Asset Value) | P/B | P/E |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Stocks | 3.59 M | — | KE KellyETFs | 0.78 | Healthcare | NYSE FactSet Global Genomics and Immuno Biopharma Index | 1/13/2022 | 10.25 | 2.86 | 14.62 | |
| Stocks | 2.59 M | 5,044 | KE KellyETFs | 0.78 | Healthcare | Strategic CRISPR & Gene Editing Technology Index - Benchmark TR Gross | 1/13/2022 | 7.38 | 1.68 | 17.02 | |
| Stocks | 972,063 | 646 | KE KellyETFs | 0.68 | Topic | Strategic Residential & Apartment Real Estate Sector Index - Benchmark TR Gross | 1/13/2022 | 9.73 | 1.43 | 26.32 | |
| Stocks | 732,132 | 202 | KE KellyETFs | 0.78 | Cyclical consumer goods | Strategic Hotel & Lodging Sector Index - Benchmark TR Gross | 1/13/2022 | 14.64 | 2.49 | 17.36 |
ETF Directory
ETF DirectoryAll asset classes
All Segments
+110 more